Souhaitez-vous accéder aux communiqués récents ?

PharmAla inks contract with Ostfold Hospital Trust in Oslo to supply clinical trial in exchange for both cash and a data license

Initial AX-0810 data show no safety signals after 4 weeks of dosing and pharmacokinetics consistent with non-clinical data; Phase 1 enrollment and dosing in healthy volunteers ongoing with target...

Science 37 Named Finalist for 2026 SCOPE Participant Engagement and Site Innovation Awards.

Quanta LOI

Fentanyl designation Response

First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 TrialBuilds on Recent Evidence of Persistent Neuroinflammation in Alzheimer’s Patients Treated with Anti-Amyloid...

MoonLake Immunotherapeutics Hit with Securities Fraud Class Action after Drug Trial Results – Contact BFA Law if You Suffered Losses

MELBOURNE, Australia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (“Gelteq” or the “Company”), a clinical and science-based company specialising in gel-based oral delivery solutions, today...

MicrobiotiX and KATH sign MoU to advance clinical bacteriophage therapies against AMR·MDR and expand treatment options for patients in Africa.

GenoSafe strengthens its leadership in analytical expertise with the opening of new GMP-compliant laboratories to support the advanced therapies sector Évry-Courcouronnes, France, November 16th, 2025...